Search

Washington: The United States Nuclear Regulatory Commission has issued the following document: GREAT LAKES TOXICOLOGY AND ECOLOGY DIVISION 6201 Congdon Boulevard, Duluth, MN 55804 February 7, 2025 Director, Office of [...]

WALTHAM: REVVITY has issued the following news release: Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has ruled in its favor and will issue a permanent injunction to [...]

WALTHAM, Mass. -- Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has ruled in its favor and will issue a permanent injunction to enforce Revvity's rights under [...]

WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences in March 2025: 46th Annual Raymond James Institutional Investor Conference Monday, March 3, [...]

ENPNewswire-February 3, 2025--Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024 (C)2025 ENPublishing - http://www.enpublishing.co.uk Release date- 31012025 - WALTHAM - Revvity, Inc. (NYSE: RVTY) today [...]

(EDGAR Online via COMTEX) -- 0000031791FALSE00000317912025-01-312025-01-310000031791us-gaap:CommonStockMember2025-01-312025-01-310000031791pki:One875NotesDue2026MemberMember2025-01-312025-01-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act [...]

Alongside a wide range of solutions unveiled for accelerating drug discovery and development Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI software at SLAS2025 in San Diego, January [...]

Unveils revolutionary solution for cellular imaging, alongside a wide range of solutions for accelerating drug discovery and development WALTHAM, Mass. -- Revvity, Inc. is set to unveil its groundbreaking new [...]

WALTHAM: Revvity has issued the following news release: Revvity, Inc. (NYSE: RVTY), today announced that it will release its fourth quarter and full year 2024 financial results prior to market [...]

WALTHAM: Revvity, Inc has issued the following news release: Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, [...]

ENPNewswire-January 14, 2025--Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing (C)2025 ENPublishing - http://www.enpublishing.co.uk Release date- 13012025 - WALTHAM, SAN DIEGO - Revvity, Inc. (NYSE: RVTY), today [...]

(EDGAR Online via COMTEX) -- 0000031791FALSE00000317912025-01-122025-01-120000031791us-gaap:CommonStockMember2025-01-122025-01-120000031791pki:One875NotesDue2026MemberMember2025-01-122025-01-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act [...]

WALTHAM, Mass. & SAN DIEGO -- Revvity, Inc. (NYSE: RVTY), today announced a strategic agreement to commercialize an in vitro diagnostic (IVD) workflow solution for neonatal sequencing, co-developed with Element [...]

WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY), today announced that it will release its fourth quarter and full year 2024 financial results prior to market open on Friday, January 31, [...]

WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY), today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for EUROIMMUN's automated chemiluminescence-based immunoassay (ChLIA) test for [...]

2025 FEB 5 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI[TM] software at SLAS2025 in San [...]

Revvity, Inc. reported it will unveil its new Phenologic.AI software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging workflows for Revvity's Harmony and Signals Image Artist [...]

M2 EQUITYBITES-January 13, 2025-Revvity and Element Biosciences partner to enhance neonatal sequencing for IVD testing (C)2025 M2 COMMUNICATIONS http://www.m2.co.uk Health science solutions provider Revvity Inc (NYSE: RVTY) announced on Monday [...]

M2 PHARMA-January 13, 2025-Revvity and Element Biosciences partner to enhance neonatal sequencing for IVD testing (C)2025 M2 COMMUNICATIONS Health science solutions provider Revvity Inc (NYSE: RVTY) announced on Monday that [...]

Washington: The United States Nuclear Regulatory Commission has issued the following document: October 18, 2024 Director of Nuclear Material Safety & Safeguards Attn: GLTS U.S. Nuclear Regulatory Commission Washington, DC [...]

WALTHAM: Revvity has issued the following news release: Revvity, Inc. (NYSE: RVTY) will present at the 43rd annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 8:15 a.m. [...]

ENPNewswire-December 18, 2024--Revvity to Present at J.P. Morgan Healthcare Conference (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 17122024 - WALTHAM - Revvity, Inc. (NYSE: RVTY) will present at the 43rd annual [...]

WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY) will present at the 43rd annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 8:15 a.m. PT in San Francisco, CA. [...]

Revvity, Inc. has announced an expansion of its work with Genomics England that leverages both organisations' expertise and resources to advance critical genomic initiatives across the United Kingdom. Building on [...]

WALTHAM: REVVITY has issued the following news release: Revvity, Inc. (NYSE: RVTY),announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance critical [...]

ENPNewswire-November 21, 2024--Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 20112024 - WALTHAM - Revvity, Inc. (NYSE: RVTY), today announced [...]

WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY), today announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance critical genomic initiatives across [...]

ENPNewswire-November 20, 2024--Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 19112024 - WALTHAM - Revvity, Inc. (NYSE: RVTY), will present at the [...]

WALTHAM: Revvity, Inc. has issued the following news release: Revvity, Inc. (NYSE: RVTY), today announced it will host an Investor Day on Thursday, November 21, 2024 at 9:00 a.m. PT [...]

WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY), will present at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024, at 8:20 a.m. ET in Coral Gables, FL. [...]

Revvity, Inc. has announced the launch of the in-vitro diagnostic EURORealTime APOE assay in European countries that accept the CE mark, which will enable accurate genotyping of the APOE gene. [...]

ENPNewswire-November 12, 2024--Cloud ELN Service Market Is in Huge Demand| Dassault Systemes, OpenText, PerkinElmer (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 11112024 - Advance Market Analytics published a new research publication [...]

(EDGAR Online via COMTEX) -- 0000031791FALSE00000317912024-11-042024-11-040000031791dei:FormerAddressMember2024-11-042024-11-040000031791us-gaap:CommonStockMember2024-11-042024-11-040000031791pki:One875NotesDue2026MemberMember2024-11-042024-11-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act [...]

ENPNewswire-November 5, 2024--Revvity Announces Financial Results for the Third Quarter of 2024 (C)2024 ENPublishing - http://www.enpublishing.co.uk Release date- 04112024 - WALTHAM - Revvity, Inc. (NYSE: RVTY), today reported financial results [...]